Through continued support from the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) and the Centers for Disease Control and Prevention (CDC) partnership, Centre for Infectious Disease Research in Zambia (CIDRZ) has been implementing capacity building and strengthening implementation of HIV combination prevention and treatment services in priority geographic locations and populations at facility, community, district, and provincial levels in the Republic of Zambia.
In order to continuously provide high quality health care services, CIDRZ held a consolidated antiretroviral therapy (ART) training targeting 15 health care providers from health posts in Lusaka.
The two day training was aimed at helping participants become aware of the new 2018 Zambia consolidated guidelines for prevention and treatment of HIV infections, understand the meaning of 90:90:90 UNAIDS targets (90% of the people living with HIV know their HIV status; 90% of the people living with HIV who know their HIV status are accessing treatment; and 90% of people living with HIV who are receiving treatment have suppressed viral load) in relation to the fight against HIV, acquire basic knowledge on ART drugs currently being used in Zambia for treatment of HIV in both adults and children and help participants know the importance of monitoring and evaluation tools available at their facilities.
The 2018 Zambia consolidated guidelines for prevention and treatment of HIV infections, provide a reference tool to health care providers and support staff on the new trends that do reflect the changes in the diagnosis, care and management of all people living with HIV in Zambia. By following recent trends and the global approach of fast-tracking towards HIV epidemic control, the Ministry of Health (MOH) hopes to achieve this through counseling leading to more individuals being tested, implementation of the universal routine HIV testing, improved linkage to care and retention through adoption of the decentralised service delivery models and better tolerated regimens leading to increased HIV treatment coverage and better virological outcomes with virological suppression and eventual reduction in new HIV infections.